Value of complete metabolic response by (18)F-fluorodeoxyglucose-positron emission tomography in oesophageal cancer for prediction of pathologic response and survival after preoperative chemoradiotherapy.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  European Journal of Cancer

• Publication date

  2007-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.EJCA.2007.04.001PMID 17512192
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Does endoscopy accurately predict response to chemoradiation in patients undergoing esophagectomy?

  2006cited by this paper
• Predictive Value of 18-Fluoro-Deoxy-Glucose-Positron Emission Tomography (18F-FDG-PET) in the Identification of Responders to Chemoradiation Therapy for the Treatment of Locally Advanced Esophageal Cancer

  2006cited by this paper
• Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus.

  2005cited by this paper
• FDG-PET in the prediction of pathologic response after neoadjuvant chemoradiotherapy in locally advanced, resectable esophageal cancer.

  2005cited by this paper
• Posttherapy pathologic stage predicts survival in patients with esophageal carcinoma receiving preoperative chemoradiation

  2005cited by this paper
• A phase II trial of preoperative one cycle of induction chemotherapy [capecitibine (CAP), CDDP] followed by concurrent chemoradiation (CRT) in patients (pts) with resectable esophageal cancer

  2005cited by this paper
• Value of baseline positron emission tomography for predicting overall survival in patient with nonmetastatic esophageal or gastroesophageal junction carcinoma

  2005cited by this paper
• The additional value of PET/CT over PET in FDG imaging of oesophageal cancer

  2005cited by this paper
• Complete response to neoadjuvant chemoradiotherapy in esophageal carcinoma is associated with significantly improved survival.

  2005cited by this paper
• A single institutional phase III trial of preoperative chemotherapy with hyperfractionation radiotherapy plus surgery versus surgery alone for resectable esophageal squamous cell carcinoma.

  2004cited by this paper
• Utility of PET, CT, and EUS to identify pathologic responders in esophageal cancer.

  2004cited by this paper
• 2‐Fluoro‐2‐deoxy‐D‐glucose positron emission tomography imaging is predictive of pathologic response and survival after preoperative chemoradiation in patients with esophageal carcinoma

  2004cited by this paper
• Positron emission tomography for assessment of the response to induction radiochemotherapy in locally advanced oesophageal cancer.

  2002cited by this paper
• Neoadjuvant Therapy of Esophageal Squamous Cell Carcinoma: Response Evaluation by Positron Emission Tomography

  2001cited by this paper
• Prediction of response to preoperative chemotherapy in adenocarcinomas of the esophagogastric junction by metabolic imaging.

  2001cited by this paper
• Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma.

  2001cited by this paper
• Endoscopic Ultrasound Does Not Accurately Assess Pathologic Stage of Esophageal Cancer after Neoadjuvant Chemoradiotherapy

  2000cited by this paper
• Phase II evaluation of preoperative chemoradiation and postoperative adjuvant chemotherapy for squamous cell and adenocarcinoma of the esophagus.

  2000cited by this paper
• Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations. European Organization for Research and Treatment of Cancer (EORTC) PET Study Group.

  1999cited by this paper
• Inadequacy of computed tomography in assessing patients with esophageal carcinoma after induction chemoradiotherapy

  1999cited by this paper
• Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus.

  1997cited by this paper
• A comparison of multimodal therapy and surgery for esophageal adenocarcinoma.

  1996cited by this paper
• Oncological applications of positron emission tomography with fluorine-18 fluorodeoxyglucose

  1996cited by this paper
• Endoscopic ultrasound in restaging of esophageal cancer after neoadjuvant chemoradiation.

  1996cited by this paper
• Lymph node mapping of esophageal cancer.

  1994cited by this paper
• Cancer : Principles and Practice of Oncology

  1982cited by this paper
• [Cancer of the esophagus].

  1960cited by this paper

• Distinct Prognostic Roles of 18F-FDG PET Metabolic Response Assessed After Induction Chemotherapy or Chemoradiotherapy in Localized Esophageal Squamous Cell Carcinoma

  2025cites this paper
• Total-Body PET/CT Metabolic Response in Esophageal Squamous Cell Carcinoma.

  2025cites this paper
• Remarkable response as a new indicator for endoscopic evaluation of local efficacy of non-surgical treatments for esophageal cancer

  2024cites this paper
• Nomogram for predicting pathologic complete response following preoperative chemoradiotherapy in patients with esophageal squamous cell carcinoma

  2023cites this paper
• Accurate Preoperative Evaluation of the Location of Esophagogastric Junction Adenocarcinoma Using Positron Emission Tomography–Computed Tomography

  2023cites this paper
• Interim position emission tomography-computed tomography during multimodality treatment of locally advanced esophageal cancer: a scoping review

  2023influential citation
• Metabolic tumour and nodal response to neoadjuvant chemotherapy on FDG PET-CT as a predictor of pathological response and survival in patients with oesophageal adenocarcinoma

  2023cites this paper
• Salvage Esophagectomy: Why it Makes Sense to Selectively Resect Squamous Cell Carcinoma

  2023cites this paper
• Can Clinical Response Predict Pathologic Response Following Neoadjuvant Chemoradiation for Esophageal Cancer?

  2022cites this paper
• Predictive Value of Endoscopic Observations and Biopsy After Neoadjuvant Chemoradiotherapy in Assessing the Pathologic Complete Response of Patients With Esophageal Squamous Cell Carcinoma

  2022cites this paper
• PET Imaging and Rate of Pathologic Complete Response in Esophageal Squamous Cell Carcinoma

  2021cites this paper
• Metabolic activity by FDG-PET/CT after neoadjuvant chemotherapy in borderline resectable and locally advanced pancreatic cancer and association with survival.

  2021cites this paper
• KSNM60 in Clinical Nuclear Oncology

  2021cites this paper
• Accuracy of Detecting Residual Disease After Neoadjuvant Chemoradiotherapy for Esophageal Cancer: A Systematic Review and Meta-analysis.

  2020influential citation
• Clinical significance of evaluating endoscopic response to neoadjuvant chemotherapy in esophageal squamous cell carcinoma

  2020cites this paper
• Utility of positron emission-computed tomography for predicting pathological response in resectable oesophageal squamous cell carcinoma after neoadjuvant chemoradiation.

  2020cites this paper
• Role of 18F-FDG PET-derived parameters for predicting complete response to chemoradiotherapy in squamous cell anal carcinoma

  2020cites this paper
• Prognostic Value of Lymph Node-To-Primary Tumor Standardized Uptake Value Ratio in Esophageal Squamous Cell Carcinoma Treated with Definitive Chemoradiotherapy

  2020cites this paper
• Novel 5‐point 18‐FDG‐PET/CT visual scoring system for assessing treatment response in patients with oesophageal or gastro‐oesophageal junction carcinoma

  2020cites this paper
• PERCISTence: Strength or Stubbornness?

  2020cites this paper
• Accuracy of 18F-FDG PET/CT in Predicting Residual Disease After Neoadjuvant Chemoradiotherapy for Esophageal Cancer

  2019cites this paper
• Phase II Feasibility and Biomarker Study of Neoadjuvant Trastuzumab and Pertuzumab With Chemoradiotherapy for Resectable Human Epidermal Growth Factor Receptor 2-Positive Esophageal Adenocarcinoma: TRAP Study.

  2019cites this paper
• Prognostic utility of FDG PET/CT in advanced ovarian, fallopian and primary peritoneal high-grade serous cancer patients before and after neoadjuvant chemotherapy

  2019cites this paper
• Detecting Pathological Complete Response in Esophageal Cancer after Neoadjuvant Therapy Based on Imaging Techniques: A Diagnostic Systematic Review and Meta-Analysis.

  2019cites this paper
• Cancers de l’œsophage

  2019cites this paper
• Favorable versus unfavorable prognostic groups by post-chemoradiation FDG-PET imaging in node-positive esophageal squamous cell carcinoma patients treated with definitive chemoradiotherapy

  2018cites this paper
• Expanding the role of positron emission tomography-computed tomography and its utility in the management of oesophageal cancer

  2018cites this paper
• Detection of residual disease after neoadjuvant chemoradiotherapy for oesophageal cancer (preSANO): a prospective multicentre, diagnostic cohort study.

  2018cites this paper
• Neoadjuvant chemoradiotherapy for resectable oesophageal cancer.

  2018cites this paper
• Role of 18F-FDG-PET/CT in Esophageal Squamous Cell Carcinoma After Neoadjuvant Chemoradiotherapy.

  2018cites this paper
• Towards an Organ-Sparing Approach for Locally Advanced Esophageal Cancer

  2018cites this paper
• Prognostic Value of Standardized Uptake Ratio in Patients with Trimodality Treatment of Locally Advanced Esophageal Carcinoma

  2018cites this paper
• 18F-FDG PET/CT for the early prediction of the response rate and survival of patients with recurrent or metastatic breast cancer

  2018cites this paper
• Surveillance versus esophagectomy in esophageal cancer patients with a clinical complete response after induction chemoradiation.

  2018influential citation
• Preoperative prediction of a pathologic complete response of esophageal squamous cell carcinoma to neoadjuvant chemoradiotherapy

  2018cites this paper
• Novel endoscopic categorization for prediction of chemoradiotherapy response in locally advanced esophageal cancer

  2018cites this paper
• Effectiveness of Repeat 18F-Fluorodeoxyglucose Positron Emission Tomography Computerized Tomography (PET-CT) Scan in Identifying Interval Metastases for Patients with Esophageal Cancer

  2017cites this paper
• Radiotherapy for esophageal carcinoma: dose, response and survival

  2017cites this paper
• FDG PET using SUVmax for preoperative T-staging of esophageal squamous cell carcinoma with and without neoadjuvant chemoradiotherapy

  2017cites this paper
• Individualized Radiation Dose Escalation Based on the Decrease in Tumor FDG Uptake and Normal Tissue Constraints Improve Survival in Patients With Esophageal Carcinoma

  2017cites this paper
• 18F-FAMT-PET Is Useful for Judging Clinical Complete Response in Advanced Esophageal Cancer Patients Who Have Received Definitive Chemoradiotherapy

  2017cites this paper
• Post-Treatment/Pre-operative PET Response Is Not an Independent Predictor of Outcomes for Patients With Gastric and GEJ Adenocarcinoma

  2017cites this paper
• Active surveillance in clinically complete responders after neoadjuvant chemoradiotherapy for esophageal or junctional cancer.

  2017cites this paper
• PET/Computed Tomography Scanning and Precision Medicine: Esophageal Cancer.

  2017cites this paper
• Metabolic Rather than Pathological Response to Preoperative Chemoradiotherapy Is a Stronger Predictor of Survival in cStage IIB-IV Esophageal Cancer.

  2017cites this paper
• Predictive value of repeated F-18 FDG PET/CT parameters changes during preoperative chemoradiotherapy to predict pathologic response and overall survival in locally advanced esophageal adenocarcinoma patients

  2016cites this paper
• Impact of PET/CT on radiation treatment in patients with esophageal cancer: A systematic review.

  2016cites this paper
• Ability of Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography to Predict Outcomes of Neoadjuvant Chemoradiotherapy Followed by Surgical Treatment for Esophageal Squamous Cell Carcinoma.

  2016cites this paper
• Change in volume parameters induced by neoadjuvant chemotherapy provide accurate prediction of overall survival after resection in patients with oesophageal cancer

  2016cites this paper
• Overexpression of HSP47 in esophageal squamous cell carcinoma: clinical implications and functional analysis.

  2016cites this paper
• Changes in Total Lesion Glycolysis Evaluated by Repeated F-18 FDG PET/CT as Prognostic Factor in Locally Advanced Esophageal Cancer Patients Treated with Preoperative Chemoradiotherapy

  2016cites this paper
• Performance of different imaging modalities in assessment of response to neoadjuvant therapy in primary esophageal cancer.

  2016cites this paper
• The predictive value of 18F-FDG PET for pathological response of primary tumor in patients with esophageal cancer during or after neoadjuvant chemoradiotherapy: a meta-analysis.

  2016cites this paper
• Performance of different imaging modalities in assessment of response to neoadjuvant therapy in primary esophageal cancer.

  2016cites this paper
• Diagnostic Applications of Nuclear Medicine: Esophageal Cancers

  2016cites this paper
• Value of functional imaging by PET in esophageal cancer.

  2015cites this paper
• Staging of esophageal adenocarcinoma by CT, PET, and other modalities

  2015cites this paper
• Multimodality treatment for locally advanced esophageal cancers

  2015cites this paper
• Clinical tools to predict outcomes in patients with esophageal cancer treated with definitive chemoradiation: are we there yet?

  2015cites this paper
• Impact of number of [18F]fluorodeoxyglucose‐PET‐positive lymph nodes on survival of patients receiving neoadjuvant chemotherapy and surgery for oesophageal cancer

  2015cites this paper
• Role of Repeat 18F-Fluorodeoxyglucose Positron Emission Tomography Examination in Predicting Pathologic Response Following Neoadjuvant Chemoradiotherapy for Esophageal Adenocarcinoma.

  2015cites this paper
• [18F]fluoro-2-deoxyglucose-positron emission tomography for the assessment of histopathological response after preoperative chemoradiotherapy in advanced oral squamous cell carcinoma

  2015cites this paper
• Predicting the Response of Neoadjuvant Therapy for Patients with Esophageal Carcinoma: an In-depth Literature Review

  2015cites this paper
• A Systematic Review of the Predictive Value of 18FDG-PET in Esophageal and Esophagogastric Junction Cancer After Neoadjuvant Chemoradiation on the Survival Outcome Stratification

  2014cites this paper
• State-of-the-art molecular imaging in esophageal cancer management: implications for diagnosis, prognosis, and treatment.

  2014cites this paper
• Role of surgical resection in complete responders on FDG‐PET after chemoradiotherapy for locally advanced esophageal squamous cell carcinoma

  2014cites this paper
• The Application of Functional Imaging Techniques to Personalise Chemoradiotherapy in Upper Gastrointestinal Malignancies

  2014cites this paper
• [18F]Fluorodeoxyglucose PET in Thoracic Malignancies.

  2014cites this paper
• Value of CT–PET after neoadjuvant chemoradiation in the prediction of histological tumour regression, nodal status and survival in oesophageal adenocarcinoma

  2014cites this paper
• 18F-fluorodeoxyglucose PET/computed tomography and risk stratification after neoadjuvant treatment in esophageal cancer patients

  2014cites this paper
• Bedeutung der PET für die Chirurgie des Ösophaguskarzinoms

  2014cites this paper
• Monitoring tumour response during chemo-radiotherapy: a parametric method using FDG-PET/CT images in patients with oesophageal cancer

  2014cites this paper
• WITHDRAWN: Multimodality treatment for locally advanced esophageal cancers

  2014cites this paper
• The Role of Maximum Standardized Uptake Value in PET/CT as a Prognostic Factor in Patients with Resected Esophageal Squamous Cell Carcinoma

  2014cites this paper
• Prognostic Significance of 18F-fluorodeoxyglucose PET Parameters for Chemoradiation of Esophageal SCC

  2013influential citation
• Prognostic significance of 18F-fluorodeoxyglucose positron emission tomography (PET)-based parameters in neoadjuvant chemoradiation treatment of esophageal carcinoma.

  2013influential citation
• Surrogate Markers: The Role of Positron Emission Tomography Scanning

  2013cites this paper
• Translation and validation of Korean Functional Assessment of Cancer Therapy-Esophageal (FACT-E) scale with squamous cell carcinoma and chemoradiation-only patients

  2012cites this paper
• Predictive and prognostic value of metabolic tumour volume and total lesion glycolysis in solid tumours

  2012cites this paper
• Evidence-based guideline recommendations on the use of positron emission tomography imaging in head and neck cancer.

  2012cites this paper
• Evidence-based guideline recommendations on the use of positron emission tomography imaging in oesophageal cancer.

  2012cites this paper
• Optimizing neoadjuvant chemotherapy through the use of early response evaluation by positron emission tomography.

  2012cites this paper
• Positron emission tomography in neoplasms of the digestive system

  2012cites this paper
• Symptomatic cardiac toxicity is predicted by dosimetric and patient factors rather than changes in 18F-FDG PET determination of myocardial activity after chemoradiotherapy for esophageal cancer.

  2012cites this paper
• The value of ¹⁸F-FDG PET/CT in assessment of metabolic response in esophageal cancer for prediction of histopathological response and survival after preoperative chemoradiotherapy.

  2012cites this paper
• 18F-fluorodeoxyglucose positron emission tomography after definitive chemoradiotherapy in patients with oesophageal carcinoma.

  2012cites this paper
• The Role of Qualitative and Quantitative Analysis of F18-FDG Positron Emission Tomography in Predicting Pathologic Response Following Chemoradiotherapy in Patients with Esophageal Carcinoma

  2012cites this paper
• Positron Emission Tomography's Utility in Esophageal Cancer Management.

  2011cites this paper
• Tips and tricks for multi-modality staging of oesophageal cancer – what you really need to know.

  2011cites this paper
• 18F-FDG PET–Guided Salvage Neoadjuvant Radiochemotherapy of Adenocarcinoma of the Esophagogastric Junction: The MUNICON II Trial

  2011cites this paper
• Positronen-Emissions-Tomographie bei Karzinomen des oberen Gastrointestinaltrakts

  2011cites this paper
• The role of PET in predicting response to chemotherapy in oesophago-gastric cancer.

  2011cites this paper
• Intra-tumor heterogeneity on baseline 18F-FDG PET images characterized by textural features predicts response to concomitant radio-chemotherapy in esophageal cancer

  2011cites this paper
• Intratumor Heterogeneity Characterized by Textural Features on Baseline 18F-FDG PET Images Predicts Response to Concomitant Radiochemotherapy in Esophageal Cancer

  2011cites this paper
• Can 18F-fluorodeoxyglucose positron emission tomography predict responses to neoadjuvant therapy in oesophageal cancer patients? A meta-analysis

  2011cites this paper
• Prediction of the Outcome of Definitive Chemoradiation by Decrease in F-18 FDG Uptake in Nonsurgical Esophageal Squamous Cell Cancer

  2011cites this paper
• Zaawansowany rak przełyku i połączenia przełykowo-żołądkowego. Możliwości i wyniki zastosowania współczesnych metod terapeutycznych Advanced cancer of esophagus and esophago-gastric junction. Applicability and effectiveness of current treatment modalities

  2011cites this paper
• 18-FLUORODEOXYGLUCOSE POSITRON EMISSION TOMOGRAPHY AS A TOOL FOR RESPONSE PREDICTION IN SOLID TUMOURS

  2010cites this paper
• SUVmax of FDG-PET correlates with the effects of neoadjuvant chemoradiotherapy for oral squamous cell carcinoma.

  2010cites this paper
• 18F-fluorodeoxyglucose positron emission tomography and computed tomography in anaplastic thyroid cancer

  2010cites this paper